FERRERI, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 509
NA - Nord America 460
AS - Asia 224
AF - Africa 58
OC - Oceania 1
Totale 1252
Nazione #
US - Stati Uniti d'America 457
GB - Regno Unito 197
VN - Vietnam 98
UA - Ucraina 94
CN - Cina 79
SE - Svezia 58
IT - Italia 45
DE - Germania 44
IN - India 33
TG - Togo 33
FR - Francia 28
ZA - Sudafrica 15
EE - Estonia 14
RU - Federazione Russa 14
SC - Seychelles 9
BE - Belgio 6
IR - Iran 6
JP - Giappone 4
CA - Canada 3
GR - Grecia 3
SA - Arabia Saudita 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
IE - Irlanda 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1252
Città #
Southend 171
Dong Ket 98
Jacksonville 73
Ann Arbor 63
Fairfield 41
Chandler 36
Princeton 35
Lomé 33
Wilmington 26
Woodbridge 23
Nanjing 17
Padova 17
Westminster 17
Seattle 16
Cambridge 15
Berlin 14
Ashburn 12
Houston 12
Mahé 9
Hebei 7
Jiaxing 7
Jinan 7
Ardabil 6
Beijing 6
Brussels 6
Milan 6
Saint Petersburg 6
Dearborn 5
Medford 5
Shenyang 5
Changsha 4
Monmouth Junction 4
Nanchang 4
Norwalk 4
Tokyo 4
Andover 3
Des Moines 3
Ningbo 3
San Diego 3
Taiyuan 3
Tianjin 3
Toronto 3
Bologna 2
Costa Mesa 2
Hangzhou 2
Kunming 2
Lanzhou 2
Leawood 2
Redwood City 2
Verona 2
Zhengzhou 2
Atlanta 1
Capannori 1
Changchun 1
Coominya 1
Cork 1
Den Haag 1
Forlì 1
Frankfurt am Main 1
Fuzhou 1
Haikou 1
Istanbul 1
Las Vegas 1
Montecatini Terme 1
Mountain View 1
Qingdao 1
Riva 1
Rome 1
Sacramento 1
San Venanzo 1
Taizhou 1
Walnut 1
Échirolles 1
Totale 875
Nome #
A Ligand of Retinoid X Receptor Overcome Multidrug Resistance in Human Colon Carcinoma LoVomdr Cell Line 114
Simple and dendritic cyclam derivative. Photophysical properties, effect of protonation and Zn++ coordination, preliminary screening as inhibitors of tumor cell growth 103
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells 96
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells 93
Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29 91
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator activated receptor-gamma 88
ANTITUMORAL EFFECT OF RETINOIDS: A COMPARISON BETWEEN ALL TRANS RETINOIC ACID AND IIF, A SPECIFIC LIGAND OF RXR 79
ANTITUMORAL EFFICACY OF RETINOIDS ON HUMAN MULTIDRUG RESISTANT COLON CARCINOMA (LOVO MDR) AND LEUKEMIA (HL60- MDR) CELL LINES 74
Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in U87MG human glioblastoma cell line, 74
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator-activated receptor gamma 69
Epigenetic Modifiers as Anticancer Drugs: Effectiveness of Valproic Acid in Neural Crest-derived Tumor Cells 67
Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells. 64
Search for multidrug resistance modulators: effects of retinoids in human colon carcinoma cells 61
Anti-invasive Effects and Proapoptotic Activity Induction by the Rexinoid IIF and Valproic Acid in Combination on Colon Cancer Cell Lines. 61
Growth inhibition and proapototic activity induction by the retinoid IIF and valproic acid on HT-29 colon cancer cell line 52
Growth Inhibition and Proapoptotic Activity Induction by IIF and Valproic Acid on RA-resistant Leukemia Cells. 46
EFFECTS OF RETINOIDS ON DRUG SENSITIVE AND MULTIDRUG RESISTANT HUMAN COLON CARCINOMA CELLS 44
Totale 1276
Categoria #
all - tutte 1530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201832 0000 00 00 00311
2018/2019164 913034 715 127 15261115
2019/2020327 84131419 1931 2539 24211028
2020/2021267 5116814 215 217 10161799
2021/2022346 36301728 2715 623 6267656
2022/2023140 3578261 00 00 0000
Totale 1276